Last Updated: November 17, 2026

Details for Patent: 10,385,341

« Back to Dashboard


Summary for Patent: 10,385,341
Title:Compositions for modulating SOD-1 expression
Abstract:Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).
Inventor(s):Eric E. Swayze
Assignee: Ionis Pharmaceuticals Inc , Biogen MA Inc
Application Number:US15/301,004
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 10,385,341

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biogen Ma QALSODY tofersen SOLUTION;INTRATHECAL 215887-001 Apr 25, 2023 RX Yes Yes 10,385,341 ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,385,341

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3126499 ⤷  Start Trial CR 2024 00038 Denmark ⤷  Start Trial
European Patent Office 3126499 ⤷  Start Trial 301293 Netherlands ⤷  Start Trial
European Patent Office 3126499 ⤷  Start Trial LUC00359 Luxembourg ⤷  Start Trial
European Patent Office 3126499 ⤷  Start Trial PA2024531 Lithuania ⤷  Start Trial
European Patent Office 3126499 ⤷  Start Trial 2024C/538 Belgium ⤷  Start Trial
European Patent Office 3126499 ⤷  Start Trial 122024000060 Germany ⤷  Start Trial
European Patent Office 3126499 ⤷  Start Trial 34/2024 Austria ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.